Cyclic (alkyl)(amino)carbenes with a six-membered backbone were prepared. Compared to their five-membered analogues, they feature increased % V and enhanced donor and acceptor properties, as evidenced by the observed n → π* transition trailing into the visible region. The high ambiphilic character even allows for the intramolecular insertion of the carbene into an unactivated C(sp)-H bond. When used as ligands, they outcompete the five-membered analogues in the palladium-mediated α-arylation of ketones with aryl chlorides.
Cyclic (alkyl)(amino)carbene (CAAC) metal complexes can also engage in asymmetric transformations, thereby expanding the toolbox of available chiral carbene ligands.
Selenium NMR has become a standard tool for scaling the p-accepting character of carbenes. Herein, we highlight that non-classical hydrogen bonding (NCHB), likely resulting from hyperconjugation, can play a significant role in the carbene-selenium 77 Se NMR chemical shift, thus triggering a non-linear behavior of the Se-Scale.
Through kinetic measurements, catalytic and stoichiometric experiments, as well as DFT calculations, we compare the catalytic activity of gold complexes supported by a variety of ligands (R3P, NHC, CAAC-5, CAAC-6, BiCAAC) in the hydroamination and hydrohydrazination of alkynes. This study provides a rationale for the superior efficiency of a gold complex bearing a bicyclic (alkyl)(amino)carbene (BiCAAC). We demonstrate that this ligand motif, which is readily available, provides a durable gold catalyst able to compete with sophisticated state-of-the-art phosphine and NHC ligands, which feature secondary interaction capabilities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.